ChiCTR-TRC-06000689
正在进行
/
/
/
2006-10-13
/
/
Intracranial atherosclerotic disease
Early stent-assisted angioplasty in symptomatic intracranial stenosis (ESASIS)
Early stent-assisted angioplasty in symptomatic intracranial stenosis (ESASIS)
Early stent-assisted angioplasty in symptomatic intracranial stenosis (ESASIS)
随机平行对照
Ⅱ期
RCT
Open label
Division of Neurology, Department of Medicine and Therapeutics; Prince of Wales Hospital, The Chinese University of Hong Kong; and Vascular and Intervention Radiology Foundation
/
200
/
2006-12-01
2012-12-31
/
1)Patient is at least 18 to 80 years of age, inclusive; 2)Acute ischemic stroke (within 4 weeks) attributable to a >70% stenosis of an intracranial artery (i.e. C6/7 internal carotid artery, M1 middle cerebral artery, V4 vertebral artery, or basilar artery) evidenced in DSA; 3)The target intracranial artery has a normal diameter of 2.00 mm to 4.5 mm; and the target area of stenosis is less than or equal to 14 mm in length; 4)A modified Rankin score of <3; 5)Patient understands the purpose and requirements of the study, can make him/herself understood, and has provided informed consent.；
登录查看Exclusion Criteria: 1)Any medical condition that would not allow the patient to adhere to the protocol or complete the study; 2)Patients for whom the required medications for the study are contra-indicated; 3)Brain infarct within previous 30 days of enrollment that is of sufficient size (> 5 cms) to be at risk of hemorrhagic conversion during or after stenting; 4)Active peptic ulcer disease, history of intracerebral (parenchymal) hemorrhage, major systemic hemorrhage within 30 days, active bleeding diathesis, platelets <100,000, hematocrit <30, INR >1.5, clotting factor abnormality that increases the risk of bleeding, alcohol or substance abuse, uncontrolled severe hypertension (systolic pressure > 180 mm Hg or diastolic pressure > 115mm Hg), severe liver impairment (SGOT > 3 x normal, cirrhosis), creatinine > 3.0 (unless on dialysis); 5)Stroke etiology other than intracranial atherosclerosis, such as cardioembolism (atrial fibrillation, prosthetic heart valve, myocardial infarction within 6 weeks, mitral stenosis, intracardiac clot, bacterial endocarditis, or ventricular aneurysm), or a tandem high-grade (>70%) proximal extra-cranial carotid or vertebral stenosis; 6)Non-atherosclerotic intracranial stenosis, such as MoyaMoya disease, fibromuscular dysplasia, vasculitis or dissection; 7)Women who are pregnant or intend to become pregnant during the study; 8)Known intracranial tumor, arterio-venous malformation or aneurysm; 9)Life expectancy less than one year; 10)Previous intracranial stenting of the target artery; 11)Major surgical operation within the past 30 days.；
登录查看Division of Neurology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong
/
药明康德2024-10-25
药渡2024-10-25
医麦客2024-10-25
小药说药2024-10-25
触界生物2024-10-24
磐霖资本2024-10-24
Pharma CMC2024-10-24
Pharma CMC2024-10-24
瑞博小核酸2024-10-24
君实医学2024-10-24
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
